• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运动病研究用运动基座驾驶模拟器的验证。

Validation of a moving base driving simulator for motion sickness research.

机构信息

Delft University of Technology, Department of Cognitive Robotics, Mekelweg 2, Delft, 2628CD, the Netherlands.

Cruden, Pedro de Medinalaan 25, Amsterdam, 1086XP, the Netherlands.

出版信息

Appl Ergon. 2023 Jan;106:103897. doi: 10.1016/j.apergo.2022.103897. Epub 2022 Oct 4.

DOI:10.1016/j.apergo.2022.103897
PMID:36206673
Abstract

Increasing levels of vehicle automation are envisioned to allow drivers to engage in other activities but are also likely to increase the incidence of Carsickness or Motion Sickness (MS). Ideally, MS is studied in a safe and controlled environment, such as a driving simulator. However, only few studies address the suitability of driving simulators to assess MS. In this study, we validate a moving base driving simulator for MS research by comparing the symptoms and time course of MS between a real-road driving scenario and a rendition of this scenario in a driving simulator, using a within-subjects design. 25 participants took part as passengers in an experiment with alternating sections (slaloming, stop-and-go) with normal and provocative driving styles. Participants performed Sudoku puzzles (eyes-off-road) during both scenarios and reported MIsery SCale (MISC) scores at 30 s intervals. Motion Sickness Assessment Questionnaire (MSAQ) scores were collected upon completion of either scenario. Overall, the results indicate that MS was more severe in the car than in the simulator. Nevertheless, significant correlations were found between individual MS in the car and simulator for 3 out of 4 MSAQ symptom categories (0.48 < r < 0.73, p < 0.02), with a strong overall correlation (r = 0.57, p = 0.004). MS onset times were similar between the car and the simulator, and sickness fluctuations as a result of driving style showed a similar pattern between scenarios, albeit more pronounced in the car. Based on observed similarities in MS, we conclude these simulator results to have relative validity. We attribute the observed reduction of MS severity in the simulator to the downscaling of the motion by the Motion Cueing Algorithm (MCA). These results suggest that, at least in eyes-off-road conditions, findings on MS from simulator studies may generalize to real vehicles after application of a conversion factor. This conversion factor is likely to depend on simulator and MCA characteristics.

摘要

车辆自动化程度的提高预计将使驾驶员能够从事其他活动,但也可能增加晕车或运动病(MS)的发生率。理想情况下,MS 是在安全和受控的环境中研究的,例如驾驶模拟器。然而,只有少数研究涉及驾驶模拟器评估 MS 的适宜性。在这项研究中,我们通过比较真实道路驾驶场景和驾驶模拟器中的该场景的呈现之间的 MS 症状和时间过程,使用受试者内设计验证了用于 MS 研究的移动基座驾驶模拟器的适用性。25 名参与者作为乘客参加了一项实验,该实验交替进行了(蛇行,走走停停)正常和挑衅性的驾驶方式。参与者在两个场景中都进行了数独谜题(视线离开道路),并在 30 秒间隔报告 MISC 评分。在完成任何一个场景后,都会收集运动病评估问卷(MSAQ)的分数。总体而言,结果表明 MS 在车内比在模拟器中更严重。尽管如此,在车内和模拟器中,4 个 MSAQ 症状类别中的 3 个(0.48<r<0.73,p<0.02)发现了 MS 个体的显著相关性,整体相关性很强(r=0.57,p=0.004)。车和模拟器之间的 MS 发作时间相似,由于驾驶方式引起的疾病波动在两个场景中表现出相似的模式,尽管在车内更为明显。基于观察到的 MS 相似性,我们得出结论,这些模拟器结果具有相对有效性。我们将模拟器中观察到的 MS 严重程度降低归因于运动提示算法(MCA)对运动的缩小。这些结果表明,至少在视线离开道路的情况下,从模拟器研究中得出的 MS 发现可以在应用转换因子后推广到真实车辆。该转换因子可能取决于模拟器和 MCA 的特点。

相似文献

1
Validation of a moving base driving simulator for motion sickness research.运动病研究用运动基座驾驶模拟器的验证。
Appl Ergon. 2023 Jan;106:103897. doi: 10.1016/j.apergo.2022.103897. Epub 2022 Oct 4.
2
Moving base driving simulators' potential for carsickness research.运动平台驾驶模拟器在晕车研究中的应用潜力。
Appl Ergon. 2019 Nov;81:102889. doi: 10.1016/j.apergo.2019.102889. Epub 2019 Jul 18.
3
Exploring the Participant-Related Determinants of Simulator Sickness in a Physical Motion Car Rollover Simulation as Measured by the Simulator Sickness Questionnaire.探究物理运动汽车翻车模拟中参与者相关因素对模拟器晕动症的影响,采用模拟器晕动症问卷进行测量。
Int J Environ Res Public Health. 2020 Sep 26;17(19):7044. doi: 10.3390/ijerph17197044.
4
Can We Study Autonomous Driving Comfort in Moving-Base Driving Simulators? A Validation Study.我们能否在运动基座驾驶模拟器中研究自动驾驶舒适性?一项验证研究。
Hum Factors. 2017 May;59(3):442-456. doi: 10.1177/0018720816682647. Epub 2016 Dec 22.
5
The effects of simulated fog and motion on simulator sickness in a driving simulator and the duration of after-effects.模拟雾和运动对驾驶模拟器中晕动病的影响及后效持续时间。
Appl Ergon. 2014 May;45(3):406-12. doi: 10.1016/j.apergo.2013.05.003. Epub 2013 May 31.
6
The use of adaptation to reduce simulator sickness in driving assessment and research.运用适应降低驾驶评估和研究中的模拟器晕动症。
Accid Anal Prev. 2013 Apr;53:127-32. doi: 10.1016/j.aap.2012.12.039. Epub 2013 Jan 23.
7
Mood and simulator sickness after truck simulator exposure.接触卡车模拟器后的情绪与模拟器不适
Int J Occup Med Environ Health. 2014 Apr;27(2):278-92. doi: 10.2478/s13382-014-0251-2. Epub 2014 Apr 1.
8
Electrogastrography in Autonomous Vehicles-An Objective Method for Assessment of Motion Sickness in Simulated Driving Environments.自主车辆中的胃电图-模拟驾驶环境中运动病评估的客观方法。
Sensors (Basel). 2021 Jan 14;21(2):550. doi: 10.3390/s21020550.
9
Motion sickness in passenger vehicles during test track operations.车辆在测试轨道运行时的晕车。
Ergonomics. 2019 Oct;62(10):1357-1371. doi: 10.1080/00140139.2019.1632938. Epub 2019 Jul 21.
10
Transition to manual: Comparing simulator with on-road control transitions.转换至手动模式:模拟器与道路控制转换的比较
Accid Anal Prev. 2017 May;102:227-234. doi: 10.1016/j.aap.2017.03.011. Epub 2017 Mar 22.

引用本文的文献

1
Personalizing motion sickness models: estimation and statistical modeling of individual-specific parameters.个性化晕动病模型:个体特异性参数的估计与统计建模
Front Syst Neurosci. 2025 Jun 16;19:1531795. doi: 10.3389/fnsys.2025.1531795. eCollection 2025.
2
Assessing Passengers' Motion Sickness Levels Based on Cerebral Blood Oxygen Signals and Simulation of Actual Ride Sensation.基于脑血氧信号评估乘客晕动病水平及实际乘车感觉模拟
Diagnostics (Basel). 2023 Apr 12;13(8):1403. doi: 10.3390/diagnostics13081403.